The role of immunoglulins in the mechanism of mucosal immunity to virus infection (Q45825783)

16 December 2017

title

The role of immunoglulins in the mechanism of mucosal immunity to virus infection (English)

1 reference

16 December 2017

author name string

Ogra PL

series ordinal

1

1 reference

16 December 2017

Karzon DT

series ordinal

2

1 reference

16 December 2017

language of work or name

1 reference

1 May 1970

1 reference

16 December 2017

Pediatric Clinics of North America

published in

1 reference

16 December 2017

volume

17

1 reference

16 December 2017

issue

2

1 reference

16 December 2017

page(s)

385-400

1 reference

16 December 2017

Studies on antibody in congenital rubella infections. I. Physicochemical and immunologic investigations of rubella neutralizing antibody

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

IDENTIFICATION OF THE ANTIVIRAL SUBSTANCES IN NASAL SECRETIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Antibody Synthesis in vitro by the Rabbit Vagina against Diphtheria Toxoid

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

MECHANISMS OF IMMUNITY AND RESISTANCE TO VIRUS INFECTIONS.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Studies on immunity to Asiatic cholera. VII. Prophylactic immunity to experimental enteric cholera

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

The mechanism of appearance of immunoglobulin A in nasal secretions in man

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

GAMMA-GLOBULINS: QUANTITATIVE RELATIONSHIPS IN HUMAN SERUM AND NONVASCULAR FLUIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Selective IgA deficiency with steatorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Studies in experimental immunology of influenza. VIII. Pathotopic adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

THE INACTIVATION OF EPIDEMIC INFLUENZA VIRUS BY NASAL SECRETIONS OF HUMAN INDIVIDUALS.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

A RATIONALE FOR STUDIES IN THE CONTROL OF EPIDEMIC INFLUENZA

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Comparative immunological studies of the immune globulins of human milk and of blood serum

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Coproantibody Excretion During Enteric Infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Physicochemical properties of reaginic antibody. 1. Association of reaginic activity with an immunoglobulin other than gammaA- or gammaG-globulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Oral polio immunization of the newborn infant; a possible method for overcoming interference by ingested antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

The gamma globulins. I. The structure and synthesis of the immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

PROGRESSIVE VACCINIA WITH NORMAL ANTIBODIES. A CASE POSSIBLY DUE TO DEFICIENT CELLULAR IMMUNITY

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

The demonstration of specific urinary anti-bodies in urinary tract infections caused by Gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Present position of immunization against poliomyelitis with live virus vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Protective effect of antibody to parainfluenza type 1 virus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

The IgA system. I. Studies of the transport and immunochemistry of IgA in the saliva

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Elevated cord macroglobulins in the diagnosis of intrauterine infections

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. II. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN ANTIGEN DOSE REQUIREMENT FOR SUSTAINED SYNTHESIS, ANAMNESIS, AND SENSITIVITY TO X-IRRADIATION.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

CHARACTERISTICS OF AN IMMUNE SYSTEM COMMON TO CERTAIN EXTERNAL SECRETIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

The human secretory immunoglobulin system: immunohistoligical localization of gamma A, secretory "piece," and lactoferrin in normal human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

Antibody formation. IV. Formation of rapidly and slowly sedimenting antibodies and immunological memory to bacteriophage phi-X 174

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2932417-8

7 January 2021

10.1016/S0031-3955(16)32417-8

Identifiers

DOI

0 references

PubMed ID

4192540

1 reference

16 December 2017